Aquestive Therapeutics, Inc. (AQST) NASDAQ
4.13
-0.03(-0.72%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.13
-0.03(-0.72%)
Currency In USD
| Market Cap | 787.91M |
| Enterprise Value | 798.18M |
| P/E Ratio | -7.35 |
| PEG Ratio | 0.61 |
| Price/Sales Ratio | 8.16 |
| Price/Book Ratio | -14.87 |
| Enterprise/Revenue | 6.82 |
| Enterprise/EBITDA | -6.46 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -1.37 |
| Operating Margin | -1.11 |
| Return On Assets | -0.49 |
| Return On Equity | 1.91 |
| Revenue | 44.55M |
| Revenue/Share | 0.41 |
| Gross Profit | 25.99M |
| EBITDA | -70.49M |
| Net Income | -83.78M |
| Diluted EPS | -0.76 |
| Total Cash | 110.73M |
| Total Cash/Share | 0.9 |
| Total Debt | 43.58M |
| Total Debt/Equity | -1.28 |
| Current Ratio | 4.1 |
| Book Value Per Share | -0.28 |
| 52-Week Change | 80.35 |
| 52-Week High | 7.55 |
| 52-Week Low | 2.15 |
| Moving Average 50 Days | 4.15 |
| Moving Average 200 Days | 4.86 |
| Average Volume | 1.66M |
| Shares Outstanding | 99.31M |
| % Held by Institutions | 65.28 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |